Condition
Granulomatosis With Polyangiitis (GPA)
Total Trials
5
Recruiting
3
Active
3
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 60/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
200%
2 of 1 completed with results
Key Signals
2 with results50% success
Data Visualizations
Phase Distribution
2Total
P 2 (2)
Trial Status
Recruiting3
Completed1
Terminated1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT02593565Recruiting
Vasculitis Pregnancy Registry
NCT03004326Recruiting
Clinical Transcriptomics in Systemic Vasculitis (CUTIS)
NCT06758271Recruiting
Special Drug Use-results Survey for Long-term Use（Avacopan）
NCT03895801Phase 2CompletedPrimary
Study of IFX-1 to Replace Steroids in Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis.
NCT03712345Phase 2TerminatedPrimary
Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPA
Showing all 5 trials